FDAnews
www.fdanews.com/articles/114894-map-pharma-8217-s-asthma-drug-fails-late-stage-study

MAP Pharma’s Asthma Drug Fails Late-Stage Study

February 24, 2009
MAP Pharmaceuticals Inc. said its experimental treatment for asthma in children failed a late-stage study, sending its shares crashing 40 percent in after-hours trading.
CNBC